1 Min Read
LONDON, Oct 3 (Reuters) - Fusion IP PLC : * Fusion portfolio company i2l - acquisition * Buys US based icr to create global biocides laboratory and field trials
contract research organisation
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.